# Zhongshan Hospital, Fudan University

Source: https://onco.cc/institutions/zhongshan-hospital-fudan/  
OnCo record `zhongshan-hospital-fudan` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Shanghai's leading general hospital and a world centre for liver cancer surgery and research, home of the Liver Cancer Institute.

## Summary

Zhongshan Hospital, founded in 1937, houses Fudan University's Liver Cancer Institute, which under Zhao-You Tang pioneered subclinical hepatocellular carcinoma detection with alpha-fetoprotein screening and small-HCC resection, and under Jia Fan and Jian Zhou continues to lead in liver transplantation for HCC, downstaging and conversion therapy, and circulating tumour cell research. The hospital is also strong in colorectal liver metastasis surgery, endoscopic resection of early gastrointestinal cancers and thoracic surgery, and its investigators contributed to the Chinese HCC immunotherapy trials. It is a national clinical research centre for interventional medicine.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: Zhongshan Hospital; 复旦大学附属中山医院
- City: Shanghai, CN
- Type: hospital
- Website: https://www.zs-hospital.sh.cn

## Sources

- Zhongshan Hospital: https://www.zs-hospital.sh.cn
- Fudan University: https://www.fudan.edu.cn

## Connected records

- cancers: [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Robotic & minimally invasive surgery](https://onco.cc/technologies/robotic-surgery/), [Thermal ablation (RFA, microwave, cryo)](https://onco.cc/technologies/thermal-ablation/)
- targets: [Glypican-3](https://onco.cc/targets/gpc3/), [PD-1](https://onco.cc/targets/pd1/), [VEGF / VEGFR](https://onco.cc/targets/vegf/)
- institutions: [Fudan University Shanghai Cancer Center](https://onco.cc/institutions/fuscc/)
- people: [Jia Fan](https://onco.cc/people/fan-jia/)
- key papers: [Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies](https://onco.cc/key-papers/paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019/)

---
JSON: https://onco.cc/api/v1/entities/zhongshan-hospital-fudan.json